Search Results - "CUTIE CHRISTOPHER" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study

by P. van Valenberg, F. Johannes, van der Heijden, Antoine G., Cutie, Christopher J., Bhanvadia, Sumeet, Keegan, Kirk A., Hampras, Shalaka, Sweiti, Hussein, Maffeo, John C., Jin, Shu, Chau, Albert, Reynolds, Donald L., Iarossi, Crysti, Kelley, April, Li, Xiang, Stromberg, Katharine A., Michiel Sedelaar, J.P., Steenbruggen, Jessica J.O., Somford, Diederik M., Alfred Witjes, J.
Published in European urology open science (Online) (01.04.2024)

Get full text

Journal Article

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

by Tyson, Mark D, Morris, David, Palou, Juan, Rodriguez, Oscar, Mir, Maria Carmen, Dickstein, Rian J, Guerrero-Ramos, Félix, Scarpato, Kristen R, Hafron, Jason M, Messing, Edward M, Cutie, Christopher J, Maffeo, John C, Raybold, Bradley, Chau, Albert, Stromberg, Katharine A, Keegan, Kirk A
Published in The Journal of urology (01.05.2023)

Get full text

Journal Article

The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial

The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial

by Daneshmand, Siamak, Brummelhuis, Iris S.G., Pohar, Kamal S., Steinberg, Gary D., Aron, Manju, Cutie, Christopher J., Keegan, Kirk A., Maffeo, John C., Reynolds, Donald L., Raybold, Bradley, Chau, Albert, Witjes, J. Alfred
Published in Urologic oncology (01.07.2022)

Get full text

Journal Article

Development and validation of a 32-gene prognostic index for prostate cancer progression

Development and validation of a 32-gene prognostic index for prostate cancer progression

by Wu, Chin-Lee, Schroeder, Brock E., Ma, Xiao-Jun, Cutie, Christopher J., Wu, Shulin, Salunga, Ranelle, Zhang, Yi, Kattan, Michael W., Schnabel, Catherine A., Erlander, Mark G., McDougal, W. Scott
Published in Proceedings of the National Academy of Sciences - PNAS (09.04.2013)

Get full text

Journal Article

METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE

METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE

by CUTIE CHRISTOPHER, GIESING DENNIS
Year of Publication 06.08.2024

Get full text

Patent

PD21-04 EXTENDED CONTINUOUS INTRAVESICAL DELIVERY OF TROSPIUM CHLORIDE SIGNIFICANTLY IMPROVES OAB SYMPTOMS OVER 12 WEEKS

PD21-04 EXTENDED CONTINUOUS INTRAVESICAL DELIVERY OF TROSPIUM CHLORIDE SIGNIFICANTLY IMPROVES OAB SYMPTOMS OVER 12 WEEKS

by Effros, Mitchell, Herman, Craig, Sussman, David, Maffeo, John, Cutie, Christopher
Published in The Journal of urology (01.04.2020)

Get full text

Journal Article

젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법

젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법

by CUTIE CHRISTOPHER, GIESING DENNIS
Year of Publication 15.07.2020

Get full text

Patent

SunRISe-1: Phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk nonmuscle-invasive bladder cancer unresponsive to Bacillus Calmette-Guérin who are ineligible for or decline radical cystectomy

SunRISe-1: Phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk nonmuscle-invasive bladder cancer unresponsive to Bacillus Calmette-Guérin who are ineligible for or decline radical cystectomy

by Van Der Heijden, Michiel Simon, Cutie, Christopher, Hampras, Shalaka, Indoria, Charu, Stewart, Rachel, Acharya, Milin, Stromberg, Katherine, Li, Xiang, Beeharry, Neil, Maffeo, John, Jacob, Joseph M
Published in Journal of clinical oncology (20.02.2022)

Get full text

Journal Article

SunRISe-4: TAR-200 plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or refuse neoadjuvant platinum-based chemotherapy

SunRISe-4: TAR-200 plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or refuse neoadjuvant platinum-based chemotherapy

by Psutka, Sarah P., Cutie, Christopher, Bhanvadia, Sumeet Kaur, Keegan, Kirk A., Crist, Wendy, Tian, Shaozhou Ken, Maffeo, John, Raybold, Bradley, Kashmer, Marietta, Hasan, Mohamad, Li, Xiang, Beeharry, Neil, Thomas, Shibu, Tian, Hui, Powles, Thomas
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

MP13-17 SUNRISE-2: A PHASE 3, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY OF TAR-200 IN COMBINATION WITH CETRELIMAB VERSUS CONCURRENT CHEMORADIOTHERAPY IN PARTICIPANTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

MP13-17 SUNRISE-2: A PHASE 3, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY OF TAR-200 IN COMBINATION WITH CETRELIMAB VERSUS CONCURRENT CHEMORADIOTHERAPY IN PARTICIPANTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

by Williams, Stephen, Cutie, Christopher, Keegan, Kirk, Raybold, Bradley, Stewart, Rachel, Acharya, Milin, Zhu, Wei, Li, Xiang, O'Dondi, Lang, Beeharry, Neil, Spratt, Daniel
Published in The Journal of urology (01.09.2021)

Get full text

Journal Article

A phase 3, multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder

A phase 3, multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder

by Williams, Stephen B., Cutie, Christopher, Keegan, Kirk A, Raybold, Bradley, Acharya, Milin, Zhu, Wei, Li, Xiang, O'Dondi, Lang A, Beeharry, Neil, Spratt, Daniel Eidelberg
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

P2-01 TAR-200 IN PATIENTS WITH BACILLUS CALMETTE–GUÉRIN-UNRESPONSIVE HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM SUNRISE-1 STUDY

P2-01 TAR-200 IN PATIENTS WITH BACILLUS CALMETTE–GUÉRIN-UNRESPONSIVE HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM SUNRISE-1 STUDY

by Necchi, Andrea, Daneshmand, Siamak, Simone, Giuseppe, Xylinas, Evanguelos, Morris, David S., Zainfeld, Daniel, Kang, Taek Won, Matulay, Justin T., Belkoff, Laurence H., Decaestecker, Karel, Arentsen, Harm, Hampras, Shalaka, Cutie, Christopher J., Sweiti, Hussein, Stromberg, Katharine, Martin, Jason, Shukla, Abhijit, van der Heijden, Michiel S., Spiegelhalder, Philipp, Jacob, Joseph M.
Published in The Journal of urology (01.05.2024)

Get full text

Journal Article

Reply by Authors

Reply by Authors

by Tyson, Mark D., Morris, David, Palou, Juan, Rodriguez, Oscar, Mir, Maria Carmen, Dickstein, Rian J., Guerrero-Ramos, Félix, Scarpato, Kristen R., Hafron, Jason M., Messing, Edward M., Cutie, Christopher J., Maffeo, John C., Raybold, Bradley, Chau, Albert, Stromberg, Katharine A., Keegan, Kirk A.
Published in The Journal of urology (01.05.2023)

Get full text

Journal Article

LBA02-03 FIRST RESULTS FROM SunRISE-1 IN PATIENTS WITH BCG UNRESPONSIVE HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER RECEIVING TAR-200 IN COMBINATION WITH CETRELIMAB, TAR-200, OR CETRELIMAB ALONE

LBA02-03 FIRST RESULTS FROM SunRISE-1 IN PATIENTS WITH BCG UNRESPONSIVE HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER RECEIVING TAR-200 IN COMBINATION WITH CETRELIMAB, TAR-200, OR CETRELIMAB ALONE

by Daneshmand, Siamak, van der Heijden, Michiel S, Jacob, Joseph M, Necchi, Andrea, Xylinas, Evanguelos, Morris, David S, Spiegelhalder, Philip, Zainfeld, Daniel, Kang, Taek Won, Matulay, Justin T, Belkoff, Laurence H, Decaestecker, Karel, Arentsen, Harm, Hampras, Shalaka, Jin, Shu, Cutie, Christopher J, Sweiti, Hussein, Stromberg, Katherine, Martin, Jason, Simone, Giuseppe
Published in The Journal of urology (01.04.2023)

Get full text

Journal Article

Safety, tolerability, and preliminary efficacy of TAR-200 in patients with intermediate risk non–muscle-invasive bladder cancer: A phase 1 study

Safety, tolerability, and preliminary efficacy of TAR-200 in patients with intermediate risk non–muscle-invasive bladder cancer: A phase 1 study

by van Valenberg, F. Johannes P., van der Heijden, Toine, Cutie, Christopher, Bhanvadia, Sumeet Kaur, Keegan, Kirk A., Hampras, Shalaka, Sweiti, Hussein, Maffeo, John, Jin, Shu, Chau, Albert, Reynolds, Don, Iarossi, Crysti, Kelley, April, Li, Xiang, Stromberg, Katherine, Sedelaar, Michiel, Steenbruggen, Jessica, Somford, Diederik Meindert, Witjes, Alfred Alfred
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

Effect of GemRIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC)

Effect of GemRIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC)

by Daneshmand, Siamak, Pohar, Kamal S., Steinberg, Gary D., Aron, Manju, Cutie, Christopher
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

METHOD OF TREATING LOWER TRACT UROTHELIAL CANCER

METHOD OF TREATING LOWER TRACT UROTHELIAL CANCER

by CUTIE CHRISTOPHER, SEARCY CHRISTOPHER, SARMA PURNANAND, GIESING DENNIS, LARRIVEE ELKINS CHERYL, AGARWAL VIKAS
Year of Publication 06.09.2022

Get full text

Patent

2309 COMPETITIVE MARKET ANALYSIS OF TRANSPLANT CENTERS AND DISCREPANCY OF PATIENT ACCESS TO KIDNEY TRANSPLANTATION

2309 COMPETITIVE MARKET ANALYSIS OF TRANSPLANT CENTERS AND DISCREPANCY OF PATIENT ACCESS TO KIDNEY TRANSPLANTATION

by Cho, Patricia, Cutie, Christopher, Kreydin, Evgeniy, Ko, Dicken
Published in The Journal of urology (01.04.2013)

Get full text

Journal Article

Reply by Authors

Reply by Authors

by Tyson, Mark D, Morris, David, Palou, Juan, Rodriguez, Oscar, Mir, Maria Carmen, Dickstein, Rian J, Guerrero-Ramos, Félix, Scarpato, Kristen R, Hafron, Jason M, Messing, Edward M, Cutie, Christopher J, Maffeo, John C, Raybold, Bradley, Chau, Albert, Stromberg, Katharine A, Keegan, Kirk A
Published in The Journal of urology (01.05.2023)

Get full text

Journal Article

Reply by Authors

Reply by Authors

by Tyson, Mark D, Morris, David, Palou, Juan, Rodriguez, Oscar, Mir, Maria Carmen, Dickstein, Rian J, Guerrero-Ramos, Félix, Scarpato, Kristen R, Hafron, Jason M, Messing, Edward M, Cutie, Christopher J, Maffeo, John C, Raybold, Bradley, Chau, Albert, Stromberg, Katharine A, Keegan, Kirk A
Published in The Journal of urology (01.05.2023)

Get full text

Journal Article